UB expert can discuss death of George Floyd, history of racial injustice in America
Kari Winter, professor of American studies, says “400 years of white supremacy have put the American dream of democracy on
Read morenews, journals and articles from all over the world.
Kari Winter, professor of American studies, says “400 years of white supremacy have put the American dream of democracy on
Read moreThe malaria drug hydroxychloroquine, which has been promoted as a potential treatment for Covid-19, is known to have potentially serious effects on heart rhythms. Now, a team of researchers has used an optical mapping system to observe exactly how the drug creates serious disturbances in the electrical signals that govern heartbeat.
Read moreResearchers from the National University of Singapore have developed a new stretchable material that can self-heal and light up. The novel material has promising applications that include damage-proof flexible display screens and illuminating electronic skin for autonomous soft robots.
Power consumption of a home refrigerator can be cut by 29% while improving cooling capacity. Researchers replaced widely-used, but environmentally
Read moreLymphoma is a type of blood cancer that develops from lymphocytes (a type of white blood cell). It has many
Read moreHalf of apartment dwellers in Los Angeles report having been exposed to unwanted secondhand smoke in their homes in the last year, and 9 in 10 of them say they favor policies banning smoking from their buildings, a new study by researchers at the Fielding School of Public Health’s UCLA Center for Health Policy Research reveals.
Read moreUCLA Asian American Studies Center and the UCLA Fielding School of Public Health COVID-19 Multilingual Resource Hub to support safety for diverse communities; partnership develops resources for COVID-19 response
Read moreScientists performed simulations of merging rotating superfluids, revealing a peculiar corkscrew-shaped mechanism that drives the fluids into rotation without the need for viscosity.
Read moreEmre Umucu, Ph.D., assistant professor of rehabilitation counseling at The University of Texas at El Paso, and Beatrice Lee, an incoming rehabilitation counseling faculty member, examined the perceived stress levels and coping mechanisms related to COVID-19, and how coping affects well-being in people with self-reported chronic conditions and disabilities.
Read moreA new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being tested by Missak Haigentz, Jr., MD, medical director of hematology and oncology for Atlantic Health System. Early results appear promising in this phase 1/2 clinical trial of ADXS-503 being developed by Advaxis, Inc., a new type of cancer therapy which targets “hotspot” mutations that commonly occur in specific cancer types, both by itself and in combination with immunotherapy Keytruda® (pembrolizumab), which is commonly used to treat this type of lung cancer. Dr. Haigentz and colleagues published early results of this study in conjunction with ASCO 2020, the world’s premier scientific meeting for clinical research in oncology.
Read moreThe more people know about when and why behavioural interventions are being used and their effectiveness, the more likely they are to accept their use to change their behaviour, according to recent research from Queen Mary University of London and the University of Oxford.
Read moreWhile many are applauding Twitter for taking a stand against misleading and incedinary Tweets, a University of Delaware professor doesn’t
Read moreFindings and the development of a new international consortium known as HoLISTIC are being shared as part of a poster presentation at the virtual 2020 American Society for Clinical Oncology Annual Meeting taking place this week.
Read moreArticle profiles Vincent Graber, his research interests and thesis plans.
Read moreFederal appellate judges are more likely to hire women to prestigious court clerkships after serving on panels with female colleagues, new Cornell research shows.
Read moreResearchers took a novel approach to tracking the virus that causes COVID-19 that promises to be cost effective and ensure privacy by using a method that surveils for the virus in a local’s untreated wastewater facilities.
Read moreProtests are erupting across the country after George Floyd died while in police custody. Video of Floyd, a black man,
Read moreThe COVID-19 pandemic has placed enormous distress on medical staff and physicians. Dr. Mark H. Greenawald, a professor at the
Read moreA recent study from the University of Washington explores the ways parasitism will respond to climate change, providing researchers new insights into disease transmission. The paper was published May 18 in Trends in Ecology and Evolution.
Read moreA West Virginia University expert on neighborhood dynamics and police procedures says that law enforcement actions in black communities will
Read moreA new study by investigators from Brigham and Women’s Hospital examines changes in prescription patterns in the United States during the COVID-19 pandemic.
Read moreFarmers in Bangladesh achieved significantly higher yields and revenues by growing insect-resistant, genetically engineered eggplant, a new Cornell study has found.
Read moreClinical oncology pathways are an important tool, helping cancer care providers and their patients to zero in on the most appropriate care plan. But a treating professional’s decision to depart from the recommendations of these decision-support resources may be well-founded and in the patient’s best interests, a new Roswell Park study shows.
Read morePhysicists at the Relativistic Heavy Ion Collider (RHIC) have demonstrated a new technique that uses bunches of electrons to cool the beams of gold ions in RHIC. The new “bunched-beam” electron cooling system keeps RHIC’s ion beams tightly packed together, especially at low energy levels, increasing the chances that the ions will collide.
Read moreA recent project increased output at the Isotope Production Facility. The project included a new particle-beam delivery system, diagnostic instruments, an adjustable targeting “iris,” and a focusing system. The project increased isotope production by 30 percent and makes possible future increases of up to 60 percent.
Read moreThis spring, the California State University will award degrees to more than 100,000 students who come from all walks of life. These students embody some of the characteristics that make the CSU’s student body so remarkable: resiliency, integrity and an eagerness to use their education to lift up those who come after them.
Expert commentary from Karen Douglas, professor of social psychology at the University of Kent, UK, whose research focuses on beliefs in
Read moreThis week in the journal Frontiers, researchers describe a single function that accurately describes all existing available data on active COVID-19 cases and deaths—and predicts forthcoming peaks.
Read moreA new report from American University shows how race influences Washington, D.C.-area residents’ daily lives and experiences, revealing a stark racial divide in perceptions among Latinos, blacks, whites and Asians about quality-of-life issues within their neighborhoods.
Read moreImagine you’re a dog. Your owner is trapped in a box and is crying out for help. Are you aware of his despair? If so, can you set him free? And what’s more, do you really want to?
Read moreWhile breakthrough treatments have emerged for several cancers over the last two decades, driving striking improvements in survival and other clinical outcomes, too little is known about the risk of therapy-related hematologic cancers following targeted and immunotherapeutic approaches. In a study to be presented at the American Society of Clinical Oncology (ASCO) 2020 virtual meeting, a Roswell Park Comprehensive Cancer Center team reports that in many cases, these newer treatment approaches may reduce the risk of therapy-related myelodysplastic syndrome or acute myeloid leukemia (tMDS/AML) compared to chemotherapy-based treatment strategies.
Read moreDespite improvements in their performance over the past decade, electronic health records (EHRs) commonly used in hospitals nationwide fail to detect up to one in three potentially harmful drug interactions and other medication errors, according to scientists at University of Utah Health, Harvard University, and Brigham and Women’s Hospital in Boston.
Read moreBy analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune checkpoint inhibitor drugs.
Read moreDue to the devastating worldwide impact of COVID-19, the illness caused by the SARS-CoV-2 virus, there has been unprecedented efforts by clinicians and researchers from around the world to quickly develop safe and effective treatments and vaccines.
Read moreResults of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
Read moreTo provide training for the expanding workforce of contact tracers, the University of Washington’s Northwest Center for Public Health Practice created the free, online course Every Contact Counts to support public health agencies — including smaller, rural public health districts and tribal health departments — to help their existing and growing workforce in the art and science of conducting a contact-tracing interview.
Read morePatients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 9556 – Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.
Read moreThe targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety of tumors harboring RET gene fusions, according to results from the international Phase I/II ARROW trial, led by researchers at The University of Texas MD Anderson Cancer Center.
Read moreA new technique overcomes a serious hurdle in the field of bacterial design and engineering
Researchers develop method to identify proteins that enable highly efficient bacterial design
Approach has potential to boost efforts in bacterial design to tackle infectious diseases, bacterial drug resistance, environmental cleanup and more
Read morePresident Trump signed an executive order May 28 that challenges the scope of Section 230 of the Communications Decency Act. The order
Read moreThe adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
Read moreLargely unaffected by the pandemic, the Daya Bay reactor neutrino experiment in Shenzen, China, has continued to pump data to remote supercomputers for analyses.
Read moreThe new COVID-19 Decision Support Dashboard synthesizes large amounts of complex, essential data into easy-to-use key findings for public and private-sector leaders navigating the “reopening” of communities and businesses.
Read moreWill schools reopen in the fall? If schools remain closed, what will be the impact on students’ education, long-term? How has the pandemic already impacted students, from elementary through higher ed; how are schools at all levels adapting to teaching virtually, and how to safely return to teaching in person – June 4, 2020 from 2-3 PM EDT
Read moreResearchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology (ASCO) annual meeting. The study evaluated patients participating in HCI’s Huntsman at Home. The data demonstrate strong evidence for this care model, showing improved patient outcomes, including reduced hospitalizations and decreased visits to the emergency department.
Read moreCharles Parrott, associate professor in the Department of Theater & Performance Studies at Kennesaw State University in Kennesaw, GA, has been selected as a 2020 Council on Undergraduate Research (CUR)–Arts and Humanities Faculty Mentor Awardee.
Read moreRubén R. Dupertuis, associate professor and department chair of religion at Trinity University in San Antonio, has been selected as a 2020 Council on Undergraduate Research (CUR)–Arts and Humanities Faculty Mentor Awardee.
Read moreResults of a Phase I clinical trial conducted by researchers at the Yale Cancer Center have shown that ARV-110, an androgen receptor PROTAC® protein degrader, demonstrates anti-tumor responses in patients with metastatic castration-resistant prostate cancer.
Read moreResearch labs have shut down around the world due to the COVID-19 pandemic, but that hasn’t stopped scientists from Woods Hole Oceanographic Institution (WHOI) from investigating critical problems in the ocean.
Read moreAn Aalto University spinoff company has come up with a way to use existing lab microscopes in a completely new and much more effective way with their innovation of nanocoated glass. While this is very relevant to covid19 research, it holds great promise for many other viruses and diseases
Read more